中国学者近期发表的论文
1.	ASXL1 alteration cooperates with JAK2V617F to accelerate myelofibrosis. Author: Guo Y1,2, Zhou Y3, Yamatomo S1,2, Yang H1,2, Zhang P1,2, Chen S1,2, Nimer SD1,2, Zhao ZJ4, Xu M1,2, Bai J5,6, Yang FC7,8. Journal: Leukemia. 2019 May;33(5):1287-1291. doi: 10.1038/s41375-018-0347-y. Epub 2019 Jan 16.    PubMed      DOI
2.	Mutant p53 enhances leukemia-initiating cell self-renewal to promote leukemia development. Author: Nabinger SC1, Chen S2, Gao R1, Yao C1,3, Kobayashi M1, Vemula S1, Fahey AC1, Wang C1, Daniels C1, Boswell HS4, Sandusky GE5, Mayo LD1, Kapur R1, Liu Y6,7. Journal: Leukemia. 2019 Jan 23. doi: 10.1038/s41375-019-0377-0. [Epub ahead of print]    PubMed      DOI
3.	CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex. Author: Schmidt L1,2, Heyes E1, Scheiblecker L1, Eder T1, Volpe G3,4, Frampton J3, Nerlov C5, Valent P6, Grembecka J7, Grebien F8,9. Journal: Leukemia. 2019 Jan 24. doi: 10.1038/s41375-019-0382-3. [Epub ahead of print]    PubMed      DOI
4.	Creating novel translation inhibitors to target pro-survival proteins in chronic lymphocytic leukemia. Author: Chen R1, Zhu M2,3, Chaudhari RR1, Robles O3, Chen Y1, Skillern W1, Qin Q1,4, Wierda WG5, Zhang S1, Hull KG2,3, Romo D6,7, Plunkett W8,9. Journal: Leukemia. 2019 Jan 30. doi: 10.1038/s41375-018-0364-x. [Epub ahead of print]    PubMed      DOI
5.	What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone? Author: Zhao H1, Huang XF1, Gao XM1, Cai H1, Zhang L1, Feng J1, Cao XX1, Zhou DB1, Li J2. Journal: Leukemia. 2019 Apr;33(4):1023-1029. doi: 10.1038/s41375-019-0391-2. Epub 2019 Jan 30.    PubMed      DOI
6.	Destabilization of AETFC through C/EBPα-mediated repression of LYL1 contributes to t(8;21) leukemic cell differentiation. Author: Zhang MM1, Liu N2, Zhang YL1, Rong B3, Wang XL1, Xu CH2, Xie YY1, Shen S4, Zhu J1, Nimer SD5, Chen Z1, Chen SJ1, Roeder RG6, Lan F3, Wang L7, Huang QH8, Sun XJ9. Journal: Leukemia. 2019 Feb 12. doi: 10.1038/s41375-019-0398-8. [Epub ahead of print]    PubMed      DOI
7.	Prognostic significance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemia. Author: Canaani J1, Labopin M2, Itälä-Remes M3, Blaise D4, Socié G5, Forcade E6, Maertens J7, Wu D8, Malladi R9, Cornelissen JJ10, Huynh A11, Bourhis JH12, Esteve J13, Mohty M2, Nagler A14,15. Journal: Leukemia. 2019 Mar 7. doi: 10.1038/s41375-019-0439-3. [Epub ahead of print]    PubMed      DOI
8.	Anti-CD19 CAR-T as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory B-ALL. Author: He X1, Xiao X2, Li Q2, Jiang Y2, Cao Y3, Sun R3, Jin X1, Yuan T2, Meng J2, Ma L2, Lu W2, Lyu C2, Liu K4, Zhao M5,6. Journal: Leukemia. 2019 Mar 7. doi: 10.1038/s41375-019-0437-5. [Epub ahead of print]    PubMed      DOI
9.	Degradation of Bruton's tyrosine kinase mutants by PROTACs for potential treatment of ibrutinib-resistant non-Hodgkin lymphomas. Author: Sun Y1, Ding N2, Song Y2, Yang Z1, Liu W3, Zhu J4, Rao Y5. Journal: Leukemia. 2019 Mar 11. doi: 10.1038/s41375-019-0440-x. [Epub ahead of print]    PubMed      DOI
10.	Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma. Author: Harrington CT1,2, Sotillo E1,3, Robert A4, Hayer KE5, Bogusz AM6, Psathas J1,7, Yu D1,8, Taylor D5,9, Dang CV10, Klein P2,11, Hogarty MD2,9,12, Geoerger B13,14, El-Deiry WS15, Wiels J4, Thomas-Tikhonenko A16,17,18,19. Journal: Leukemia. 2019 Mar 26. doi: 10.1038/s41375-019-0454-4. [Epub ahead of print]    PubMed      DOI

同类著名期刊名称 h-index CiteScore BLOOD 426 18.60 Journal of Hematology & Oncology 60 15.20 AMERICAN JOURNAL OF HEMATOLOGY 92 9.20 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 111 10.10 BLOOD REVIEWS 85 10.70 BRITISH JOURNAL OF HAEMATOLOGY 172 8.10 SEMINARS IN HEMATOLOGY 88 7.10 TRANSFUSION MEDICINE REVIEWS 65 7.40 HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA 74 5.60 CURRENT OPINION IN HEMATOLOGY 90 5.60

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 301668 CANCER RESEARCH 166473 Molecular Medicine Reports 165309 International Journal of Nanomedicine 164985 CANCER LETTERS 160117 JOURNAL OF ETHNOPHARMACOLOGY 142368 BIOMEDICINE & PHARMACOTHERAPY 141587 Theranostics 136617 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 136489 International Journal of Environmental Research and Public Health 134176